Johnson David Michael's Form 4 filing
Aura Biosciences, Inc. (AURA) · filed Jan 9, 2023
- Accession no.
- 0000899243-23-001324
- Filed
- Jan 9, 2023
- Trade date
- Jan 5-6, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $20.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Johnson David MichaelCIK 0001808098 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Common Stock | PPurchaseAcquired | +300 | $10.00 | +$3,000 | 17,300 | Indirect | |
| Jan 5, 2023 | Common Stock | PPurchaseAcquired | +96 | $10.00 | +$960 | 17,096 | Indirect | |
| Jan 6, 2023 | Common Stock | PPurchaseAcquired | +700 | $10.50 | +$7,350 | 18,000 | Indirect | |
| Jan 6, 2023 | Common Stock | PPurchaseAcquired | +904 | $10.51 | +$9,501.04 | 18,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.